Helicobacter pylori infection in children

Current Problems in Pediatrics

Volumn 31, Issue 8, 2001, Pages 247-266

  Gold, Benjamin D ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; DNA VACCINE; NITROIMIDAZOLE DERIVATIVE; PROBIOTIC AGENT; PROTON PUMP INHIBITOR; VACCINE;

ABDOMINAL PAIN; ADULT; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; ARTICLE; CHILD; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DIGESTIVE SYSTEM ULCER; DUODENUM ULCER; GASTRITIS; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DISEASE; GENE SEQUENCE; GRAM NEGATIVE INFECTION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MEDICAL RESEARCH; PATHOGENESIS; PRACTICE GUIDELINE; PRESCHOOL CHILD; STOMACH BIOPSY; STOMACH CANCER; STOMACH DISEASE; STOMACH LYMPHOMA; UNITED STATES; ZOONOSIS;

EID: 0035212841     PISSN: 00459380     EISSN: None     Source Type: Journal    
DOI: 10.1067/mps.2001.118485     Document Type: Article

References (209)

1. Unidentified curved bacilli on gastric epithelium in active chronic gastritis
2. Campylobacter pyloridis and gastritis in children
3. Association of Campylobacter pylori on the gastric mucosa with antral gastritis in children
4. Campylobacter-like organisms in association with symptomatic gastritis in children
5. Campylobacter pyloridis in children
6. Campylobacter pyloridis-associated primary gastritis in children
7. Peptic ulcer disease in children: Etiology, clinical findings, and clinical course
8. Susceptibility of Campylobacter pyloridis to three macrolide antibiotics (erythromycin, roxithromycin [RU 28965], and CP 62,993) and rifampin
9. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease
10. Canadian Helicobacter pylori consensus conference. Canadian Association of Gastroenterology
11. Helicobacter pylori infection in children: A consensus statement
12. Canadian Helicobacter Study Group Consensus Conference on the Approach to Helicobacter pylori infection in Children and Adolescents
13. Helicobacter pylori infection in children: Recommendations for diagnosis and treatment
14. A comprehensive review of the natural history of Helicobacter pylori infection in children
15. Characteristics of Helicobacter pylori infection in Jamaican adults with gastrointestinal symptoms
16. High prevalence of Helicobacter pylori in the Alaska native population and association with low serum ferritin levels in young adults
17. Helicobacter pylori: Epidemiology and routes of transmission
18. Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States
19. Recent developments in the epidemiology of Helicobacter pylori
20. Helicobacter pylori virulence and genetic geography
21. Association of Helicobacter pylori infection with gastric cancer
22. Transmission of Helicobacter pylori among siblings
23. Transmission of Helicobacter pylori: Is it all child's play [comment]?
24. The prevalence of self-reported peptic ulcer in the United States
25. The incidence of Helicobacter pylori infection
26. Prevalence of Helicobacter pylori infection in children from urban and rural West Virginia
27. Helicobacter pylori infection and eradication in paediatric patients
28. A population-based serologic survey of Helicobacter pylori infection in children and adolescents in the United States
29. Natural history of Helicobacter pylori infection in childhood: 12-year follow-up cohort study in a biracial community
30. Increasing prevalence of Helicobacter pylori infection with age: Continuous risk of infection in adults rather than cohort effect
31. In a world of black and white, Helicobacter pylori is gray
32. Hypothesis: The changing relationships of Helicobacter pylori and humans: Implications for health and disease
33. Pervasive occult gastrointestinal bleeding in an Alaska native population with prevalent iron deficiency. Role of Helicobacter pylori gastritis
34. Helicobacter pylori Sero-Incidence in a cohort of rural Bolivian children
35. The incidence of Helicobacter pylori (Hp) acquisition in children of a Northern Manitoba aboriginal community: Evidence of parent-to-child transmission
36. The transmission of Helicobacter pylori. A critical review of the evidence
37. Transmission of Helicobacter pylori: Faecal-oral versus oral-oral route
38. Fecal and oral shedding of Helicobacter pylori from healthy infected adults
39. Detection of a vacuolating cytotoxin in stools from children with diarrhea
40. Helicobacter pylori in Melbourne Chinese immigrants: Evidence for oral-oral transmission via chopsticks
41. Helicobacter pylori infection in dentists - A case-control study
42. Isotypic analysis of specific antibody response in serum, saliva, gastric and rectal homogenates of Helicobacter pylori-infected patients
43. Detection of Helicobacter pylori in oral aphtous ulcers
44. Microbial ecology and treatment of Helicobacter pylori infections: Review
45. Immunomagnetic separation and PCR for detection of Helicobacter pylori in water and stool specimens
46. Vector potential of houseflies (Musca domestica) for Helicobacter pylori
47. Helicobacter pylori isolated from the domestic cat: Public health implications
48. Characterization of feline Helicobacter pylori strains and associated gastritis in a colony of domestic cats
49. Water source as risk factor for Helicobacter pylori infection in Peruvian children. Gastrointestinal Physiology Working Group
50. Pretreatment with ureal-hydrochloric acid enhances the isolation of Helicobacter pylori from contaminated specimens
51. Prevalence of and risk factors for Helicobacter pylori infection in school children in Mexico
52. Epidemiology of Helicobacter pylori infection in children: A serologic study of the Kyushu region in Japan
53. Effect of environmental and substance factors on survival and growth of Helicobacter pylori
54. Helicobacter pylori infection and mode of transmission in a population at high risk of stomach cancer
55. Helicobacter pylori infection occurs via close contact with infected individuals in early childhood
56. Seroprevalence of Helicobacter pylori infection in patients with hepatitis B
57. Survival of Helicobacter pylori in milk and tap water
58. Evaluation of two commercial serologic tests for the diagnosis of Helicobacter pylori infection in the rhesus monkey
59. Helicobacter pylori-induced gastritis in the domestic cat
60. Failure to isolate Helicobacter pylori from stray cats indicates that H pylori in cats may be an anthroponosis - An animal infection with a human pathogen
61. High prevalence of Helicobacter pylori infection in shepherds
62. Helicobacter pylori in sheep milk
63. Houeflies as reservoir for Helicobacter pylori
64. Houseflies are an unlikely reservoir or vector for Helicobacter pylori
65. Review article: Have we foudn the source of Helicobacter pylori?
66. Genomic-sequence comparison of two related isolates of the human gastric pathogen Helicobacter pylori
67. Geographic distribution of vacA allelic types of Helicobacter pylori
68. The disease spectrum of Helicobacter pylori: The immunopathogenesis of gastroduodenal ulcer and gastric cancer
69. Helicobacter pylori in childhood: New insights into the immunopathogenesis of gastric disease and implications for managing infection in children
70. Not all Helicobacter pylori strains are created equal: Should all be eliminated [see comments]?
71. Heterogeneity of Helicobacter pylori
72. Helicobacter pylori eradication and its implications for the future
73. The only Helicobacter pylori is a dead Helicobacter pylori
74. H pylori and cagA: Relationships with gastric cancer, duodenal ulcer, and reflux esophagitis and its complications
75. Genotypic, clinical, and demograghic characteristics of children infected with Helicobacter pylori
76. Cag, a pathogenicity island of Helicobacter pylori, encodes type I-Specific and disease-associated virulence factors
77. Cosnervation of the cag pathogenicity island of Helcobacter pylori: Associations with vacuolating cytotoxin allele and IS605 diversity
78. Moisaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration
79. The clinical relevance of strain types of Helicobacter pylori
80. Helicobacter pylori vacA, iceA, and cagA status and pattern of gastritis in patients with malignant and benign gastroodenal disease
81. Frequency of vacA genotypes and cytotoxin activity in Helicobacter pylori associated with low-grade gastric mucosa-associated lymphoid tissue lymphoma
82. The vacuolating cytotoxin of Helicobacter pylori
83. Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori
84. Typing of Helicobacter pylori vacA gene and detectiopn of caga gene by PCR and reverse hybridization
85. Distinctiveness of genotypes of Helicobacter pylori in Calcutta, India
86. Differences in genotypes of Helicobacter pylori from different human populations
87. Functional organization and insertion specificity of IS607, a chimetric element of Helicobacter pylori
88. Cost savings in duodenal ulcer therapy through Helcobacter pylori eradication compared with conventional therapies: Results of a randomized doubled-blind, multicenter trial
89. Long-term treatment with lansoprazole of patients with duodenal ulcer and basal acid output of more than 15 mmol/h
90. Gastric secretion of acid and pepsin in patients with esophageal stricture and approapriate controls
91. Peptic ulcer disease in children. Diagnosis, treatment and the implication of Helicobacter pylori
92. Helicobacter pylori, gastric ulcer, and duodenal ulcer
93. Are genetic influences on peptic ulcer dependent or independent of genetic influences for Helicobacter pylori infection?
94. Intrafamilial clustering of Helicobacter pylori infection
95. Does maternal smoking hinder mother-child transmission of Helicobacter pylori infection?
96. Interleukin-1 polymorphisms associated with increased risk of gastric cancer
97. Helicobacter pylori, gastric atrophy and intestinal metaplasia in children
98. Increased macrophage infiltration of gastric mucosa in Helicobacter pylori-infected children
99. Helicobacter pylori gastritis in children and adults: Comparative histopathologic study
100. Treating biopsies to cure patients: The management of histological findings in mucosa-associated lymphoid tissue (MALT)
101. Atrophy, acid suppression and Helicobacter pylori infection: A tale of two studies
102. Recognizing atrophy: Another step toward a classification of gastritis
103. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994
104. Helicobacter pylori (Hp) and gastroesophageal reflux disease in children: A relationship [abstract]?
105. cagE is a virulence factor associated with Helicobacter pylori-induced duodenal ulceration in children
106. Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: A model
107. Attempt to fulfil Koch's postulates for pyloric Campylobacter
108. Helicobacter pylori infection, host genes, and disease outcome
109. The gastric cardia in Helicobacter pylori infection
110. Simultaneous visualization of Helicobacter pylori and gastric morphology: A new stain
111. Helicobacter pylori in childhood: New insights into the immunopathogenesis of gastric disease and implications for managing infection in children
112. Histopathology of gastroduodenal inflammation: The impact of Helicobacter pylori
113. Campylobacter associated gastritis in patients with non-ulcer dyspepsia
114. Helicobacter pylori prevalence in non-ulcer dyspepsi- ethnic and socio-economic differences
115. Unique features of Helicobacter pylori disease in children
116. The influence of Helicobacter pylori on oesophageal acid exposure in GERD during acid suppressive therapy
117. Gastric precancerous lesions: Heading for an international consensus
118. Campylobacter pyloridis, gastritis, and peptic ulceration
119. Campylobacter pyloridis and gastritis
120. Antral nodularity, gastric lymphoid hyperplasia, and Helicobacter pylori in adults
121. Epidemiology of peptic ulcer disease and Helicobacter pylori (Hp) in hospitalized children using the Pediatric Hospital Information System
122. From bench to bedside to bug: An update of clinically relevant advances in the care of persons with Helicobacter pylori-associated diseases
123. Association of gastric metaplasia and duodenitis with Helicobacter pylori infection in children
124. Prevalence of CagA, VacA antibodies in symptomatic and asymptomatic children with Helicobacter pylori infection
125. H pylori-CagA serum antibody and RAP in children
126. Long-term effect of Helicobacter pylori eradication on gastric metaplasia in patients with duodenal ulcer
127. Association between infection with Helicobacter pylori and risk of gastric cancer: Evidence from a prospective investigation
128. Declining incidence of gastric cancer
129. Risk of stomach cancer in patients with peptic ulcer disease
130. Increased prevalence of precancerous changes in relatives of gastric cancer patients: Critical role of H pylori
131. Helicobacter pylori infection and the risk of gastric carcinoma
132. The etiology of gastric cancer
133. Helicobacter pylori and gastric carcinogenesis
134. Gastric carcinoma risk index in patients infected with Helicobacter pylori
135. Effect of Helicobacter pylori eradication on malignant transformation of gastric adenoma
136. Atrophy and intestinal metaplasia one year after cure of H pylori infection: A prospective, randomized study
137. Canadian Helicobacter study group consensus conference on the approach to Helicobacter pylori infection in children and adolescents
138. New approaches to Helicobacter pylori infection in children
139. Pediatric Helicobacter pylori infection: Clinical manifestations, diagnosis, and therapy
140. Immunophenotyping in the management of gastric lymphoma
141. The role of Helicobacter pylori in primary gastric MALT lymphoma
142. Lymphoma of the gastrointestinal tract
143. Helicobacter pylori and lymphoproliferative disorders
144. Helicobacter pylori infection and gastric lymphoma
145. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma
146. Gastrointestinal lymphomas of T- and B-cell types
147. Mucosa-associated lymphoid tissue lymphoma
148. Recent advances in our understanding of the biology and pathogenesis of gastric mucosa-associated lymphoid tissue (malt) lymphoma
149. Treatment of gastric MALT lymphoma by Helicobacter pylori eradication: A study controlled by endoscopic utralsonography
150. Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoik tissue. An uncontrolled trial
151. Eradication of Helicobacter pyloriand stability of remissions in low-grade gastric B-cell lymphomas of the mucosa-associated lymphoid tissue: Results of an ongoing multicenter trial
152. When can complete regression of low-grade gastric lymphoma of mucosa-associated lymphoid tissue be predicted after Helicobacter pylori eradication?
153. Resolution of Helicobacter pylori-associated gastric lymphoproliferative disease in a child
154. Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia
155. Eradication of Helicobacter pylori affects symptoms in nonulcer dyspepsia
156. Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia
157. Eradication of Helicobacter pylori in functional dyspepsia: Randomised double blind placebo controlled trial with 12 months' follow up
158. Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia
159. Helicobacter pylori, gastroduodenal disease, and recurrent abdominal pain in children
160. Helicobacter pylori and childhood recurrent abdominal pain: Community based case-control study
161. Helicobacter pylori infection and childhood recurrent abdominal pain: Lack of evidence for a cause and effect relationship
162. The prevalence of Helicobacter pylori serum antibodies in children with recurrent abdominal pain
163. Recurrent abdominal pain and Helicobacter pylori in a community-based sample of London children
164. Helicobacter pylori, hypergastrinaemia, and recurrent abdominal pain in children
165. Helicobacter pylori and recurrent abdominal pain in children
166. Helicobacter pylori infection in recurrent abdominal pain in childhood: Comparison of diagnostic tests and therapy
167. Helicobacter pylori and abdominal symptoms: A population-based study among preschool children in southern Germany
168. Association of symptoms with Helicobacter pylori infection in children
169. Campylobacter pylori-related gastrointestinal disease in children. Incidence and clinical findings
170. Helicobacter pylori infection in children. Is there specific symptomatology?
171. Primary antral gastritis in young American children. Low prevalence of Helicobacter pylori infections
172. Gastroesophageal reflux disease: Prevalence, clinical, endoscopic and histopathological findings in 1,128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms
173. Helicobacter pylori infection is associated with milder gastro-oesophageal reflux disease
174. Association of Helicobacter pylori genotype with gastroesophageal reflux disease and other upper gastrointestinal diseases
175. Endoscopic regression of Barrett's oesophagus during omeprazole treatment; a randomised double blind study
176. Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection
177. Noninvasive diagnosis of Helicobacter pylori infection: A review
178. Use caution with serologic testing for Helicobacter pylori infection in children
179. Comparison of biopsy and serological methods of diagnosis of Helicobacter pylori infection and the potential role of antibiotics
180. Prospective comparison of H&E, Giemsa, and Genta stains for the diagnosis of Helicobacter pylori
181. Early diagnosis of signet righ cell carcinoma of the stomach: Role of the Genta stain
182. Are there three types of Helicobacter pylori gastritis?
183. Biopsy sites suitable for the diagnosis of Helicobacter pylori infection and the asessment of the extent of atrophic gastritis
184. Diagnosis of Helicobacter pylori infection: Non-invasive diagnostic tests
185. Urea breath tests for the detection of Helicobacter pylori infection
186. The 13C-urea blood test accurately detects active Helicobacter pylori infection: A United States, multicenter trial
187. Gastric bacterial overgrowth is a cause of false positive diagnosis of Helicobacter pylori infection using 13C urea breath test
188. Testing for Helicbacter pylori in clinical practice
189. Comparison between a rapid office-based and ELISA serologic test in screening for Helicobacter pylori in children
190. Serodiagnosis of Helicobacter pylori in pediatric patients
191. Accurate diagnosis of Helicobacter pylori infection by stool antigen test and 6 other currently available tests in children
192. Helicobacter pylori stool antigen (HpSa) test-a simple, accurate and non-invasive test for detection of Helicobacter pylori infection
193. Usefulness of Helicobacter pylori stool antigent test to monitor response to eradication treatment in children
194. Diagnosis of Helicobacter pylori infection with a new non-invasive antigen-based assay
195. Non-gastrointestinal tract association of Helicobacter pylori infection
196. Guidelines for the management of Helicbacter pylori infection. Ad Hoc Committee on Practice Paramenters of the American College of Gastroenterology
197. Treatment of Helicobacter pylori infection: A review
198. Current regimens for treatment of Helicobacter pylori infection
199. Helicobacter pylori: Rational management options
200. Treatment after failure: The problem of "non-responders"
201. Longterm follow-up of duodenal ulcer in children before and after eradication of Helicobacter pylori
202. Antibiotic-resistant H pylori infection and its treatment
203. Metronidazole containing quadruple therapy for infection with metronidazole resistant Helicobacter pylori: A prospective study
204. Clarithromycin-resistant Helicobacter pylori in patients with duodenal ulcer in the United States
205. Dual versus triple therapy of Helicobacter pylori infecton: Results of a multicentre trial
206. Metronidazole resistance reduces efficacy of triple therapy and leads to secondary clarithromycin resistance
207. Characteristics and trends in macrolide resistance among Helicobacter pylori strains isolated in Bulgaria over four years
208. Demonstration of unexpected antibiotic resistance of genotypically identical Helicobacter pylori isolates
209. Effect of pretreatment antibiotic resistance to metronidazole and clarithromycin on outcome of Helicobacter pylori therapy: A meta-analytical approach